The effect of levonorgestrel-releasing intrauterine device on menorrhagia in women taking anticoagulant medication after cardiac valve replacement

Sevtap KilicLeyla Mollamahutoglu


This study was conducted to evaluate the effect of levonorgestrel-releasing intrauterine devices (LNG-IUDs) on menorrhagia in patients receiving anticoagulant therapy after cardiac valve replacement. Forty women with menorrhagia who underwent cardiac valve replacement and were taking anticoagulant medication were enrolled in the study. The women were randomly divided into two groups: LNG-IUDs were inserted into 20 women in Group 1 over the first 3 days of menstrual bleeding, while the women in Group 2 were followed without any intervention. The activated partial thromboplastin time, prothrombin time, international normalized ratio, hematocrit level, hemoglobin level, ferritin level and pictorial bleeding assessments for the quantity of menstrual bleeding were recorded. Three months after insertion of LNG-IUDs, the women in Group 1 had a significant decrease in blood loss and higher hemoglobin, hematocrit and ferritin values. No difference was detected for these parameters in the control group at the third and sixth months of the study. Coagulation parameters did not differ between the two groups. LNG-IUDs can be considered as an effective non-surgical treatment for menorrhagia in women receiving anticoagulant therapy after card...Continue Reading


Aug 1, 1990·British Journal of Obstetrics and Gynaecology·J M HighamR W Shaw
Jan 1, 1986·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·S G SilverbergT Luukkainen
Jan 5, 1995·The New England Journal of Medicine·D T Durack
Feb 21, 2006·BJOG : an International Journal of Obstetrics and Gynaecology·R A BusfieldN Johnson
May 29, 2007·Contraception·Rezan A Kadir, Claudia Chi

❮ Previous
Next ❯


Jun 16, 2012·Human Reproduction Update·UNKNOWN ESHRE Capri Workshop GroupAnna Glasier
Oct 15, 2014·Clinical Obstetrics and Gynecology·Suji Uhm, Lisa Perriera
Aug 23, 2011·Acta Obstetricia Et Gynecologica Scandinavica·Kristina Gemzell-DanielssonOskari Heikinheimo
May 28, 2013·The American Journal of Cardiology·Antonia Pijuan-DomènechJaume Casaldàliga-Ferrer
Mar 13, 2018·Obstetrics and Gynecology·Adam Bonnington, Amy M Autry
Mar 30, 2018·Clinical Obstetrics and Gynecology·Andrew Rivara, Andra H James
Mar 10, 2018·Clinical Obstetrics and Gynecology·Beverly GrayAndra H James
Nov 3, 2017·Blood·Kochawan BoonyawatShannon M Bates
Jun 21, 2019·Journal of Thrombosis and Haemostasis : JTH·Ingrid M BistervelsSaskia Middeldorp
Feb 12, 2015·Obstetrical & Gynecological Survey·Johannes BitzerIan S Fraser
May 1, 2015·The Cochrane Database of Systematic Reviews·Anne LethabyMargaret C Rees
Dec 4, 2016·Hematology·Andra H James
Jun 13, 2020·The Cochrane Database of Systematic Reviews·Magdalena Bofill RodriguezVanessa Jordan

❮ Previous
Next ❯

Related Concepts

Related Feeds


Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.